Macrolide and statin interaction — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Increased risk of statin toxicity and rhabdomyolysis
Clarithromycin inhibits CYP3A4 and can substantially increase simvastatin exposure. This increases the risk of myopathy and rhabdomyolysis. The prescriber should be contacted about withholding simvastatin or using a different antibiotic where appropriate. The patient should be advised to report muscle pain, weakness or dark urine.
Reference: BNF; NICE CKS